Table 2 Demographics, characteristics, and management of patients with alcohol use disorder seen by the CLP service

Age (mean ± standard deviation)

43 ± 20.15

Gender

Male

124 (74.7%)

Female

42 (25.3%)

Consultation type

Emergency consult

112 (67.5%)

Floor consult

54 (32.5%)

Duration of alcohol use in years (mean ± standard deviation)

15.1 ± 14.41

Comorbid substance use disorder (y/n)

Stimulant (cocaine) use disorder

30 (18.1%)

Sedative, hypnotic, or anxiolytic (benzodiazepine) use disorder

25 (15.1%)

Cannabis use disorder

23 (13.9%)

Opioid use disorder

19 (11.4%)

Other substance use disorders

26 (15.7%)

Comorbid mental condition or disorder (y/n)

Suicidality

30 (18%)

Anxiety disorder

23 (13.8%)

Mood disorder

23 (13.8%)

Psychotic disorder

3 (1.8%)

Personality disorder

2 (1.2%)

Others

16 (9.6%)

Comorbid related hepatological or neurological complications (y/n)

44 (26.5%)

Previous alcohol use disorder treatment (y/n)

66 (39.8%)

Previous inpatient medically assisted withdrawal (y/n)

39 (23.5%)

History of withdrawal seizures (y/n)

15 (9%)

History of delirium tremens (y/n)

9 (5.4%)

Pharmacological recommendation (y/n)

Lorazepam

62 (37.3%)

Diazepam

13 (7.8%)

Other benzodiazepines

13 (7.8%)

Gabapentin

3 (1.8%)

Acamprosate

1 (0.6%)

Disulfiram

1 (0.6%)

Thiamine

76 (45.8%)

Folic acid

10 (3.6%)

Medically assisted withdrawal

Fixed-dose regimen

36 (21.9%)

Symptom-triggered regimen

20 (12%)

Combined treatment

17 (10.2%)

Application of CIWA by the primary team (y/n)

78 (47%)

Outcome of restraint application (y/n)

0 (0%)

Outcome of intensive care unit admission (y/n)

32 (19.2%)

Outcome of intubation (y/n)

13 (7.8%)